Samrat Pharmachem (BOM:530125) EPS (Basic) : ₹28.82 (TTM As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Samrat Pharmachem EPS (Basic)?

Samrat Pharmachem's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was ₹9.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹28.82.

Samrat Pharmachem's EPS (Diluted) for the three months ended in Dec. 2024 was ₹9.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹28.82.

Samrat Pharmachem's EPS without NRI for the three months ended in Dec. 2024 was ₹9.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 26.53.

During the past 12 months, Samrat Pharmachem's average EPS without NRIGrowth Rate was 99999999.99% per year. During the past 3 years, the average EPS without NRI Growth Rate was -38.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 13.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was 42.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Samrat Pharmachem's highest 3-Year average EPS without NRI Growth Rate was 123.70% per year. The lowest was -55.90% per year. And the median was 27.15% per year.

Samrat Pharmachem EPS (Basic) Historical Data

The historical data trend for Samrat Pharmachem's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samrat Pharmachem EPS (Basic) Chart

Samrat Pharmachem Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EPS (Basic)

Get a 7-Day Free Trial

13.71

17.26

55.62

53.83

7.00

Samrat Pharmachem Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EPS (Basic)	Get a 7-Day Free Trial															1.11	4.52	6.68	8.61	9.01

Samrat Pharmachem EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Samrat Pharmachem's Basic EPS for the fiscal year that ended in Mar. 2024 is calculated as

Basic EPS (A: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(21.626	-	0)	/	3.090
	=	7.00

Samrat Pharmachem's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(27.848	-	0)	/	3.091
	=	9.01

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹28.82

Samrat Pharmachem (BOM:530125) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Samrat Pharmachem EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Samrat Pharmachem's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Samrat Pharmachem Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Samrat Pharmachem Ltd (BOM:530125) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

M. A. Road, 701/702, Business Square, Andheri (West), Mumbai, MH, IND, 400 058

Website

https://www.samratpharmachem.com

Samrat Pharmachem Ltd is a producer of pharmaceutical chemicals. The principal activity of the company is to manufacture Iodine salts and bromine salts. Its product portfolio consists of potassium iodate, potassium iodide, methyl iodide, and copper iodide. Its products are used in various industries like pharmaceuticals and chemicals.

Samrat Pharmachem Headlines

No Headlines